니코틴 껌 시장 : 유형별, 유통 채널별, 지역별

Global Nicotine Gum Market is estimated to be valued at USD 1.90 Bn in 2024 and is expected to reach USD 3.10 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.

Figure. Nicotine Gum Market Share (%), By Region 2024

Nicotine gum is a medicated chewing gum that delivers nicotine to the body and is used as an aid to quit smoking. Nicotine gum works by releasing small doses of nicotine into the bloodstream when chewed. This satisfies the nicotine cravings of the user and reduces the withdrawal symptoms experienced when quitting smoking. The global nicotine gum market is driven by the growing number of individuals attempting to quit the smoking habit. Furthermore, the rising awareness about the health hazards of smoking and the benefits of nicotine gum in cessation is also fueling the demand for nicotine gum products worldwide. However, stringent regulations pertaining to the sale and use of nicotine gum may hinder the market growth in the coming years.

Market Dynamics:

The global nicotine gum market is driven by factors such as the increasing number of smokers wanting to quit smoking, growing awareness about the health issues of smoking, and wider availability and acceptance of chewing gum as an alternative to cigarettes. However, strict regulations regarding the sale and marketing of nicotine gum products restrain the growth of the market. Furthermore, the introduction of innovative nicotine delivery methods and alternative smoking cessation products pose a threat to convention nicotine gums. Major players are investing in R&D to develop technologically advanced nicotine gum formulations for better effectiveness and convenience. This is expected to present lucrative opportunities for market players in the near future.

Key features of the study:

This report provides in-depth analysis of the global nicotine gum market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.

It profiles key players in the global nicotine gum market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.

Key companies covered as a part of this study include GlaxoSmithKline plc , Johnson & Johnson, Novartis Consumer Health , ITC Limited , Cipla Health Limited, Perrigo Company Plc, Fertin Pharma, Alchem International, Revolymer, British American Tobacco Plc, and Philips Morris International Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.

The global nicotine gum market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nicotine gum market.

Market Segmentation

• By Type Insights (Revenue, USD Bn, 2019 - 2031)
  • 2 mg
  • 4 mg
  • 6 mg
• By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
  • Supermarkets
  • Hypermarkets
  • Pharmacies
  • Online Stores
• Regional Insights (Revenue, USD Bn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Novartis Consumer Health
  • ITC Limited
  • Cipla Health Limited
  • Perrigo Company Plc
  • Fertin Pharma
  • Alchem International
  • Revolymer
  • British American Tobacco Plc
  • Philips Morris International Inc

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Nicotine Gum Market, By Type
  • Nicotine Gum Market, By Distribution Channel
  • Nicotine Gum Market, By Region

3. Market Dynamics, Regulations, And Trends Analysis

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Nicotine Gum Market, By Type, 2024-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• 2 mg
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• 4 mg
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• 6 mg
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Nicotine Gum Market, By Distribution Channel, 2024-2031, (USD Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2019 - 2031
  • Segment Trends
• Supermarkets
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Hypermarkets
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Online Stores
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Nicotine Gum Market, By Region, 2024 - 2031, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2019 - 2031, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Bn)
  • Market Size and Forecast, By Country, 2019 - 2031, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

7. Competitive Landscape

• GlaxoSmithKline plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Johnson & Johnson
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis Consumer Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• ITC Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cipla Health Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Perrigo Company Plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Fertin Pharma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Alchem International
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Revolymer
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• British American Tobacco Plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Philips Morris International Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

8. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

9. References and Research Methodology

• References
• Research Methodology
• About us